Equine rhinitis A virus (ERAV) is an important respiratory pathogen of horses and is of additional interest because of its close relationship and common classification with foot-and-mouth disease virus (FMDV). As is the case with FMDV, the VP1 capsid protein of ERAV has been shown to be a target of neutralizing antibodies. In FMDV VP1, such antibodies commonly recognize linear epitopes present in the βG–βH loop region. To map linear B cell epitopes in ERAV VP1, overlapping fragments spanning its length were expressed in Escherichia coli as glutathione S-transferase (GST) fusion proteins. These fusion proteins were tested for reactivity with sera from ERAV-infected horses and with polyclonal sera from ERAV-immunized rabbits and mice. Regions at the N- and C-termini as well as the βE–βF and the βG–βH loop regions contained B cell epitopes that elicited antibodies in the natural host. GST fusion proteins of these regions also elicited antibodies following immunization of rabbits and mice, which, in general, strongly recognized native ERAV VP1 but which were non-neutralizing. It is concluded that the N-terminal region of ERAV VP1, in particular, contains strong B cell epitopes.
AcharyaR.,
FryE.,
StuartD.,
FozG.,
RowlandsD.,
BrownF.1989; The three-dimensional structure of foot-and-mouth disease virus at 2·9 Å resolution. Nature 337:709–716
BerinsteinA.,
RoivainenM.,
HoviT.,
MasonP. W.,
BaxtB.1995; Antibodies to the vitronectin receptor (integrin α Vβ 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol 69:2664–2666
CrabbB. S.,
MacPhersonC. M.,
ReubelG. H.,
BrowningG. F.,
StuddertM. J.,
DrummerH. E.1995; A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch Virol 140:245–258
CurryS.,
FryE.,
BlakemoreW.,
Abu-GhazalehR.,
JacksonT.,
KingA.,
LeaS.,
NewmanJ.,
StuartD.1997; Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol 71:9743–9752
DanenE. H.,
AotaS. I.,
van KraatsA. A.,
YamadaK. M.,
RuiterD. J.,
van MuijenG. N.1995; Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin α 5β 1
. J Biol Chem 270:21612–21618
DiMarchiR.,
BrookeG.,
GaleC.,
CracknellV.,
DoelT.,
MowatN.1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
FricksC. E.,
HogleJ. M.1990; Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol 64:1934–1945
HartleyC. A.,
FicorilliN.,
DynonK.,
DrummerH. E.,
HuangJ. A.,
StuddertM. J.2001; Equine rhinitis A virus: structural proteins and immune response. J Gen Virol 82:1725–1728
JacksonT. J.,
SheppardD.,
DenyerM.,
BlakemoreW.,
KingA. M. Q.2000; The epithelial integrin α vβ 6 is a receptor for foot-and-mouth disease virus. J Virol 74:4949–4956
LiF.,
BrowningG. F.,
StuddertM. J.,
CrabbB. S.1996; Equine rhinovirus 1 is more closely related to foot-and-mouth disease virus than to other picornaviruses. Proc Natl Acad Sci U S A 93:990–995
LuoM.,
RossmannM. G.,
PalmenbergA. C.1988; Prediction of three-dimensional models for foot-and-mouth disease virus and hepatitis A virus. Virology 166:503–514
MateuM. G.,
AndreuD.,
DomingoE.1995; Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210:120–127
PingL. H.,
LemonS. M.1992; Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol 66:2208–2216
RueckertR. R.2001; Picornaviridae : the viruses and their replication. In Fields Virology , 4th edn. pp 685–715 Edited by
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott–Raven;
VarrassoA.,
DrummerH. E.,
HuangJ. A.,
StevensonR. A.,
FicorilliN.,
StuddertM. J.,
HartleyC. A.2001; Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus. J Virol 75:10550–10556
WarnerS.,
HartleyC. A.,
StevensonR. A.,
FicorilliN.,
VarrassoA.,
StuddertM. J.,
CrabbB. S.2001; Evidence that equine rhinitis A virus is a target of neutralizing antibodies and participates directly in receptor binding. J Virol 75:9274–9281
WutzG.,
AuerH.,
NowotnyN.,
GrosseB.,
SkernT.,
KuechlerE.1996; Equine rhinovirus serotypes 1 and 2: relationship to each other and to aphthoviruses and cardioviruses. J Gen Virol 77:1719–1730
XieQ. C.,
McCahonD.,
CrowtherJ. R.,
BelshamG. J.,
McCulloughK. C.1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol 68:1637–1647